Adaptiiv Medical Technologies Raises Nearly $1M in Exempt Securities Offering

The healthcare technology firm completed a private debt and warrant-based fundraising under SEC Rule 506(b).

February 03, 2025

Key Details of the Offering

Adaptiiv Medical Technologies Inc., a healthcare technology company based in Halifax, Nova Scotia, has successfully raised $969,792 through an exempt securities offering. The company utilized Rule 506(b) of Regulation D, which allows capital raising from accredited investors without the need for full SEC registration.

The total offering amount was fully subscribed, with all securities sold to eight accredited investors. The investment structure involved a combination of debt and warrants. Notably, no sales commissions or finder’s fees were paid in connection with the transaction. Additionally, there was no minimum investment requirement, making participation more flexible for investors.

Corporate and Leadership Structure

Adaptiiv Medical Technologies has been incorporated in Nova Scotia for over five years and focuses on advancing healthcare technology. The company declined to disclose its revenue range in the filing, listing itself under the “Other” industry group, which indicates a specialized market focus.

Key executives and directors named in the filing include CEO Alex Dunphy, as well as board members Travis Gay, Gene Salkind, Andrew Bolwell, Josh Levine, and Bruce Ross. The filing also confirmed that none of the proceeds from this capital raise would be used for payments to these executives or other promoters.

No Business Combination or Public Offering Plans

Adaptiiv Medical Technologies clarified that this offering was not conducted in connection with any merger, acquisition, or other business combination. Additionally, the company confirmed that the offering would not extend beyond one year.

By utilizing the Rule 506(b) exemption, Adaptiiv maintained its private investment structure, limiting participation to accredited investors and avoiding public market registration. This regulatory strategy enables the company to efficiently secure funding while maintaining greater control over its financing terms.

This latest capital raise positions Adaptiiv Medical Technologies for continued growth as it advances its healthcare innovations. With nearly $1 million in fresh capital, the company is well-positioned to execute its strategic initiatives and expand its impact within the medical technology sector.